510(k) device
Access hsTnI
Beckman Coulter, Inc. · Immunoassay Method, Troponin Subunit (MMI, Class II) · First FDA decision Dec 4, 2023, newest Aug 1, 2025Heart attack (myocardial infarction)Heart attack and heart failure blood tests
Last checked: Nov 21, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
4
510(k) pathway
Device trials
0
Naming "Access hsTnI"
MAUDE reports
17
Brand "Access hsTnI", since 2015
PubMed studies
17
Mentioning "Access hsTnI"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Access hsTnI
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 4 of 4 decisions filed under this name.
- Access hsTnI510(k)
K243483 · Decided Aug 1, 2025 · 266 days after receipt
Device type: Immunoassay Method, Troponin Subunit (MMI) · Laboratory Medicine & Pathology
3 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Access hsTnI", any status and sponsor, newest update first.
No registered device study names "Access hsTnI".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Access hsTnI", and for the whole product code for context.
This brand
17 reports: 1 malfunction, 16 injury, 0 death
Whole product code MMI
7,546 reports: 7,009 malfunction, 528 injury, 4 death
Newest reports for this brand
- ACCESS HSTNIInjury
2122870-2026-00001 · Received Jan 2, 2026 · Event dated Dec 19, 2025
Device type: Immunoassay Method, Troponin Subunit (MMI)
Device problem as coded: High Test Results
Patient problem as coded: Insufficient Information
4 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-0727-2025 · Started Nov 18, 2024 · Posted by FDA Dec 20, 2024
Reason given: Beckman Coulter, Inc. is recalling their Access hsTnI assay, a medical device by correction. The reason for the recall is: high troponin antigen (>55,000 pg/mL) can contaminate an analyzers probe and cause inter-assay carryover due to insufficient washing. The contamination can cause a falsely elevated Access hsTnI...
Cause as FDA categorized it: Component design/selection · Device type: Immunoassay Method, Troponin Subunit (MMI)
Published research
The most relevant PubMed records for "Access hsTnI"[tiab]. The summary above synthesizes these.
- Assessment of Access hsTnI 99th percentiles upper reference limits following IFCC recommendations.
Di Pietro M, Dipalo M, Rocchi MBL, et al. · Clin Chim Acta · 2019
- A critical evaluation of the Beckman Coulter Access hsTnI: Analytical performance, reference interval and concordance.
Pretorius CJ, Tate JR, Wilgen U, et al. · Clin Biochem · 2018Evaluation Study
- Evaluation of the new Beckman Coulter Access hsTnI: 99th percentile upper reference limits according to age and sex in the Korean population.
Kim S, Yoo SJ, Kim J · Clin Biochem · 2020Evaluation Study
- Suspected myocardial infarction in the emergency department: An evaluation of clinical thresholds for the Beckman Coulter Access hsTnI high-sensitivity cardiac troponin I assay.
Meek R, Cullen L, Lu Z, et al. · Emerg Med Australas · 2023
- Evaluation of the Atellica TnIH cardiac troponin I assay and assessment of biological equivalence.
Pretorius CJ, Parsonage W, Cullen LW, et al. · Clin Chem Lab Med · 2022Research Support, Non-U.S. Gov't
- Diagnostic value of a point-of-care cardiac troponin-I assay (i-STAT®) for clinical application in canine and feline cardiology.
Ferasin L, Ferasin H, Farminer J, et al. · J Vet Cardiol · 2024
- Validation of a 0-/2-Hour High-Sensitivity Cardiac Troponin Algorithm for Suspected Acute Coronary Syndrome in the Emergency Department.
Mark DG, Huang J, Lee KK, et al. · J Am Heart Assoc · 2025Validation Study, Multicenter Study
- Potential impact of a novel pathway for suspected myocardial infarction utilising a new high-sensitivity cardiac troponin I assay.
Meek R, Cullen L, Lu ZX, et al. · Emerg Med J · 2022
- Validation of Rapid Rule-Out Criteria Using the Beckman Access hsTnI Assay for Patients With Suspected Myocardial Infarction in a Cardiac Emergency Department.
Meek R, Weiner O, Venkatesan S, et al. · Emerg Med Australas · 2025Validation Study
- Identifying low-risk patients within the observation zone of a 0/2-h high-sensitivity troponin diagnostic protocol for chest pain evaluation.
DiLena DD, Huang J, Rauchwerger AS, et al. · Int J Cardiol · 2025Multicenter Study, Research Support, Non-U.S. Gov't
- Analytical comparison of three different versions of a high-sensitivity cardiac troponin I assay over 10years.
Kavsak PA, Worster A, Hill SA, et al. · Clin Chim Acta · 2017Comparative Study
- Myocardial Infarction Can Be Safely Excluded by High-sensitivity Troponin I Testing 3 Hours After Emergency Department Presentation.
Peacock WF, Christenson R, Diercks DB, et al. · Acad Emerg Med · 2020Multicenter Study
Other devices of this type
Also filed under product code MMI.
- Elecsys Troponin T Gen 5Roche Diagnostics · 510(k) 2021
- i-STAT hs-TnI cartridge with the i-STAT Alinity SystemAbbott Point of Care, Inc. · 510(k) 2026
- VITROS Immunodiagnostic Products hs Troponin I Reagent PackOrtho-Clinical Diagnostics, Inc. · 510(k) 2025
- Atellica® IM High-Sensitivity Troponin I (TnIH)Siemens Healthcare Diagnostics, Inc. · 510(k) 2024
- Alinity i STAT High Sensitivity Troponin-IAbbott Laboratories Diagnostics Division · 510(k) 2023
- Vidas Troponin I Ultra (Tniu) Assay, Model 30 448bioMerieux, Inc. · 510(k) 2007
- Dimension Vista Ctni Flex Reagent CartridgeDade Behring, Inc. · 510(k) 2007
- Abbott Axsym Troponin-I AdvAbbott Laboratories · 510(k) 2006
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.